Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 927-20-8
2. Magnesium 1-glycerophosphate
3. Magnesium Alpha-glycerophosphate
4. Magnesium;2,3-dihydroxypropyl Phosphate
5. 89i3knz71g
6. Glycerol, 1-(dihydrogen Phosphate), Magnesium Salt (1:1)
7. 1,2,3-propanetriol, 1-(dihydrogen Phosphate), Magnesium Salt (1:1)
8. Unii-89i3knz71g
9. Einecs 213-149-3
10. Mfcd00153014
11. Rac-glycero-3-phosphate Magnesium Salt
12. Schembl730522
13. Magnesium Glycerol 1-(dihydrogen Phosphate) (1:1)
14. Dtxsid00919002
15. Magnesium Glycerophosphate Hydrate
16. Magnesium 1,2,3-propanetriol 1-(dihydrogen Phosphate) (1:1)
17. Magnesium 2,3-dihydroxypropyl Phosphate
18. Magnesium Glycerophosphate Hydrate, Powder
19. Anhydrous Magnesium Glycerophosphate
20. Dl- Alpha -glycerol Phosphate Magnesium Salt
21. Ft-0699916
22. Rac-glycero-1-phosphate, Magnesium Salt
23. Phosphoric Acid 2,3-dihydroxypropyl=magnesium Salt
24. Dl--glycerol Phosphate Magnesium Salt Hydrate
25. Dl-alpha-glycerolphosphatemagnesiumsalthydrate
26. Q18211488
Molecular Weight | 194.36 g/mol |
---|---|
Molecular Formula | C3H7MgO6P |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 193.9830666 g/mol |
Monoisotopic Mass | 193.9830666 g/mol |
Topological Polar Surface Area | 113 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 117 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Magnesium Glycerophosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium Glycerophosphate, including repackagers and relabelers. The FDA regulates Magnesium Glycerophosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium Glycerophosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magnesium Glycerophosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magnesium Glycerophosphate supplier is an individual or a company that provides Magnesium Glycerophosphate active pharmaceutical ingredient (API) or Magnesium Glycerophosphate finished formulations upon request. The Magnesium Glycerophosphate suppliers may include Magnesium Glycerophosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium Glycerophosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Magnesium Glycerophosphate written confirmation (Magnesium Glycerophosphate WC) is an official document issued by a regulatory agency to a Magnesium Glycerophosphate manufacturer, verifying that the manufacturing facility of a Magnesium Glycerophosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Magnesium Glycerophosphate APIs or Magnesium Glycerophosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Magnesium Glycerophosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Magnesium Glycerophosphate suppliers with Written Confirmation (WC) on PharmaCompass.
Magnesium Glycerophosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium Glycerophosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium Glycerophosphate GMP manufacturer or Magnesium Glycerophosphate GMP API supplier for your needs.
A Magnesium Glycerophosphate CoA (Certificate of Analysis) is a formal document that attests to Magnesium Glycerophosphate's compliance with Magnesium Glycerophosphate specifications and serves as a tool for batch-level quality control.
Magnesium Glycerophosphate CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium Glycerophosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium Glycerophosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium Glycerophosphate EP), Magnesium Glycerophosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium Glycerophosphate USP).
LOOKING FOR A SUPPLIER?